<DOC>
	<DOCNO>NCT00572910</DOCNO>
	<brief_summary>This study evaluate safety immunogenicity V710 without Merck Aluminum Adjuvant ( MAA ) adult participant end-stage kidney disease hemodialysis .</brief_summary>
	<brief_title>A Study Evaluate Safety Immunogenicity V710 Adults With Kidney Disease Hemodialysis ( V710-005 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Staphylococcal Infections</mesh_term>
	<criteria>Diagnosed end stage kidney disease hemodialysis Female patient able child must negative urine pregnancy test Developed serious infection within past 12 month ; allergy component vaccine Has vaccinate live virus within past 30 day schedule vaccinated live virus next 60 day Received V710 vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>